Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.

Biotechnology

Kedalion Therapeutics

Kedalion Therapeutics' headquarters in Menlo Park, CA, United States

Mark Blumenkranz

Mark Murray

Ehud Ivri

Casey Dougan

John Power

Judy Gordon

Daniel Palanker

Charles Bosworth

Dana Mead

Marc Gleeson

Richard Lewis

William Culbertson

Richard Lindstrom

Darius Kharabi

John Berdahl

Description

People (2)

Mark Blumenkranz

Reynaldo Quintana

Jobs